Initiator Pharma A/S (STO: INIT)

Initiator Pharma Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 4, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	432	485	317	356	133	188
Market Cap Growth	47.44%	52.80%	-10.94%	167.93%	-29.18%	153.41%
Enterprise Value	410	475	268	318	121	175
Last Close Price	7.70	9.24	6.06	8.14	4.51	7.47
PE Ratio	-	-14.20	-5.08	-9.80	-10.51	-15.58
PB Ratio	14.98	29.13	6.23	7.36	6.84	13.51
P/FCF Ratio	-23.22	-18.42	-6.48	-7.56	-12.22	-15.65
P/OCF Ratio	-23.22	-18.42	-6.48	-7.56	-12.22	-15.65
EV/EBITDA Ratio	-	-	-4.29	-9.96	-8.56	-13.50
EV/EBIT Ratio	-18.94	-11.79	-4.29	-9.95	-8.54	-13.37
EV/FCF Ratio	-21.99	-18.05	-5.48	-6.74	-11.16	-14.60
Debt / Equity Ratio	-	1.38	0.37	0.38	-	-
Debt / FCF Ratio	-	-0.87	-0.38	-0.39	-	-
Quick Ratio	15.40	9.34	26.54	7.10	13.01	6.89
Current Ratio	15.40	9.34	27.70	9.91	13.06	7.45
Return on Equity (ROE)	-72.71%	-101.24%	-111.44%	-85.27%	-71.53%	-62.60%
Return on Assets (ROA)	-43.56%	-43.24%	-51.13%	-41.61%	-48.68%	-40.58%
Return on Capital (ROIC)	-48.81%	-46.16%	-54.99%	-46.00%	-54.13%	-44.09%
Earnings Yield	-3.35%	-7.04%	-18.15%	-8.18%	-8.83%	-6.19%
FCF Yield	-4.31%	-5.43%	-15.43%	-13.24%	-8.18%	-6.39%
Buyback Yield / Dilution	-3.02%	-7.60%	-51.69%	-28.17%	-12.92%	-20.72%
Total Shareholder Return	-3.02%	-7.60%	-51.69%	-28.17%	-12.92%	-20.72%

Source: S&P Capital IQ. Standard template. Financial Sources.